The actions of chloride channel blockers, barbiturates and a benzodiazepine on Caenorhabditis elegans glutamate- and ivermectin-gated chloride channel subunits expressed in Xenopus oocytes
2009
Bush, Elizabeth | Foreman, Richard | Walker, Robert J | Holden-Dye, Lindy
The pharmacology of Caenorhabditis elegans glutamate-gated chloride (GluCl) channels was determined by making intracellular voltage-clamp recordings from Xenopus oocytes expressing GluCl subunits. As previously reported (Cully et al. 1994), GluClα1β responded to glutamate (in a picrotoxin sensitive manner) and ivermectin, while GluClβ responded only to glutamate and GluClα1 only to ivermectin. This assay was used to further investigate the action of chloride channel compounds. The arylaminobenzoate, NPPB, reduced the action of glutamate on the heteromeric GluClα1β channel (IC₅₀ 6.03 ± 0.81 μM). The disulphonate stilbene, DNDS, blocked the effect of both glutamate and ivermectin on GluClα1β channels, the action of glutamate on GluClβ subunits, and the effect of ivermectin on GluClα1 subunits (IC₅₀s 1.58-3.83 μM). Surprisingly, amobarbital and pentobarbital, otherwise known as positive allosteric modulators of ligand-gated chloride channels, acted as antagonists. Both compounds reduced the action of glutamate on the GluClα1β heteromer (IC₅₀s of 2.04 ± 0.5 and 17.56 ± 2.16 μM, respectively). Pentobarbital reduced the action of glutamate on the GluClβ homomeric subunit with an IC₅₀ of 0.59 ± 0.09 μM, while reducing the responses to ivermectin on both GluClα1β and GluClα1 with IC₅₀s of 8.7 ± 0.5 and 12.9 ± 2.5 μM, respectively. For all the antagonists, the mechanism is apparently non-competitive. The benzodiazepine, flurazepam had no apparent effect on these glutamate- and ivermectin-gated chloride channel subunits. Thus, arylaminobenzoates, disulphonate stilbenes, and barbiturates are non-competitive antagonists of C. elegans GluCl channels.
显示更多 [+] 显示较少 [-]